Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 4/20 | 0.68 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.68 |
| ▸ | KDR | P35968 | 3/20 | 0.68 |
| ▸ | PDE5A | O76074 | 2/20 | 0.54 |
| ▸ | GBA1 | P04062 | 1/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23577267 | 1.00 | EGFR (0.68) | EGFRPDGFRBKDRPDE5AGBA1 | |
| SCHEMBL29909096 | 0.91 | EGFR (0.76) | EGFRPDGFRBKDRPDE5AGBA1 | |
| SCHEMBL3110618 | 0.91 | EGFR (0.76) | EGFRPDGFRBKDRPDE5AGBA1 | |
| Hydrochloric Acid SCHEMBL9776746 | 0.89 | EGFR (0.74) | EGFRPDGFRBKDRPDE5AGBA1 | |
| SCHEMBL3106603 | 0.86 | EGFR (0.74) | EGFRPDGFRBKDRPDE5AGBA1 | |
| SCHEMBL2262123 | 0.86 | EGFR (0.74) | EGFRPDGFRBKDRPDE5AGBA1 | |
| SCHEMBL3113257 | 0.85 | EGFR (0.72) | EGFRPDGFRBKDRPDE5A | |
| SCHEMBL30013867 | 0.84 | EGFR (0.60) | EGFRPDGFRBKDRPDE5AGBA1 | |
| SCHEMBL23577438 | 0.84 | EGFR (0.60) | EGFRPDGFRBKDRPDE5AGBA1 | |
| SCHEMBL23576885 | 0.84 | EGFR (0.71) | EGFRPDGFRBKDRPDE5AGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324767-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2024-07-12 | — | — | CN | disclosed |
| CN-115362003-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2022-11-18 | — | — | CN | disclosed |